Podcasts about milind kamkolkar

Jim Joyce and I had a great time hanging with Milind Kamkolkar today on "Shot of #DigitalHealth Therapy". We went deep into human biology (well as deep as we can in ~40 min): ✅ Invention vs. Innovation ✅ Advances in understanding of cell behaviors ✅ Doing things better or doing better things! ✅ Drug Discovery and #AI ✅ TechBio or #Biotech ✅ Creating legacy when creating companies Fun mentions: Cellarity Flagship Pioneering B Capital Group Jessica DaMassa Jay Bradner Atomwise Insilico Medicine Alex Zhavoronkov Mathai Mammen and many more.

Milind Kamkolkar joined Cellarity in January 2019 to help the company to prove that it is now possible to "encode a cell" digitally—to use big data, deep learning, and other methods to model many different interconnected networks of molecular interactions.  "The whole idea...is really only feasible now," he says. "What changed over the last number of years is the ability to compute at scale."The promise of Cellarity's computational models, Kamkolkar says, is that they look broadly at cell behavior, rather than taking a reductionist approach. "If you could see the forest and the trees, what does that look like?" he says. "Really taking into account all of these networks that exist not only at the molecular level, not only at the cellular level, but also at the tissue level, and being able to look at all of it at once. You could argue it sound quite preposterous, but I love the ambition."Kamkolkar joined Cellarity from Sanofi, where he was the industry's first enterprise chief data officer, driving the transformation of Sanofi into a data-driven organization. Previously he was the global head of data science and AI and digital medicine at Novartis.This episode is part of a special series of interviews with speakers at the AI Applications Summit produced by Corey Lane Partners. Check out the full show notes and other MoneyBall Medicine episodes at our website.Please rate and review MoneyBall Medicine on Apple Podcasts! Here's how to do that from an iPhone, iPad, or iPod touch:• Launch the “Podcasts” app on your device. If you can’t find this app, swipe all the way to the left on your home screen until you’re on the Search page. Tap the search field at the top and type in “Podcasts.” Apple’s Podcasts app should show up in the search results.• Tap the Podcasts app icon, and after it opens, tap the Search field at the top, or the little magnifying glass icon in the lower right corner.• Type MoneyBall Medicine into the search field and press the Search button.• In the search results, click on the MoneyBall Medicine logo.• On the next page, scroll down until you see the Ratings & Reviews section. Below that you’ll see five purple stars.• Tap the stars to rate the show.• Scroll down a little farther. You’ll see a purple link saying “Write a Review.”• On the next screen, you’ll see the stars again. You can tap them to leave a rating, if you haven’t already.• In the Title field, type a summary for your review.• In the Review field, type your review.• When you’re finished, click Send.• That’s it, you’re done. Thanks!

In this episode Harry talks with Milind Kamkolkar, chief data officer at Sanofi, about how big pharma can start using new data sources to uncover new insights about disease. This is Part 2 of a special 6-part series of episodes recorded at the AI Applications Summit produced in Boston by Corey Lane Partners in October 2018. How to rate MoneyBall Medicine on iTunes with an iPhone, iPad, or iPod touch: Launch the "Podcasts" app on your device. If you can't find this app, swipe all the way to the left on your home screen until you're on the Search page. Tap the search field at th top and type in "Podcasts." Apple's Podcasts app should show up in the search results. Tap the Podcasts app icon, and after it opens, tap the Search field at the top, or the little magnifying glass icon in the lower right corner. Type MoneyBall Medicine into the search field and press the Search button. In the search results, click on the MoneyBall Medicine logo. On the next page, scroll down until you see the Ratings & Reviews section. Below that you'll see five purple stars. Tap the stars to rate the show. Scroll down a little farther. You'll see a purple link saying "Write a Review." On the next screen, you'll see the stars again. You can tap them to leave a rating, if you haven't already. In the Title field, type a summary for your review. In the Review field, type your review. When you're finished, click Send. That's it, you're done. Thanks!

Data, artificial intelligence and machine learning are having a profound influence on healthcare, drug discovery, and personalized medicine. On this episode, CXOTalk host, Michael Krigsman, talks with two data experts innovating in healthcare with data.Milind Kamkolkar is the CDO of Sanofi, a company focused on empowering lives through human health. Hicham Oudghiri is Co-founder and CEO of Enigma.

Data, artificial intelligence and machine learning are having a profound influence on healthcare, drug discovery, and personalized medicine. On this episode, CXOTalk host, Michael Krigsman, talks with two data experts innovating in healthcare with data.Milind Kamkolkar is the CDO of Sanofi, a company focused on empowering lives through human health. Hicham Oudghiri is Co-founder and CEO of Enigma.

November 4th - 7th 2017 the global community of innovators in medicine convened at the beautiful Hotel Del Coronado to share insights on topics ranging from blockchain applications in medicine and health services generally to robotics to the use of artificial (or 'augmented') intelligence and beyond. Moderated by the talented and boundlessly energetic Daniel Kraft, MD (follow @daniel_kraft) some refer to this annual pilgrimage as the 'burning man' equivalent for passionate innovators in the medical, healthtech, medical device, precision medicine and emerging 'omics' space. The faculty and schedule of events us available here, a conference mashup, here. For true addicts of the innovation impulse, prior talks are available here. This year Health Innovation Media's focus was on quality and depth of interviews vs. the prior years' focus on quantity of conversations logged. In this interview I chat with Malind Kamkolkar (follow @milindkam), Chief Data Officer, Sanofi a company focused on empowering lives through human health. Milind’s focus is driving and transforming Sanofi from a data generation organization to an insights generating organization where data is a monetizable asset on par with product and shareholder value. Enjoy!

What does digital transformation mean for drug companies? Milind Kamkolkar, Chief Data Officer at Sanofi, speaks with CXOTalk co-hosts Richie Etwaru and Michael Krigsman about innovation and changes in the pharmaceutical industry.Sanofi is a company focused on empowering lives through human health. As CDO, Kamkolkar focuses on driving and transforming Sanofi from data generation to an insights generating organization where data is a monetizable asset class on par with product and shareholder value.

What does digital transformation mean for drug companies? Milind Kamkolkar, Chief Data Officer at Sanofi, speaks with CXOTalk co-hosts Richie Etwaru and Michael Krigsman about innovation and changes in the pharmaceutical industry.Sanofi is a company focused on empowering lives through human health. As CDO, Kamkolkar focuses on driving and transforming Sanofi from data generation to an insights generating organization where data is a monetizable asset class on par with product and shareholder value.

The 2016 gathering of the global community congealing under the banner of Exponential Medicine and curated by the digital health evangelist Daniel Kraft, MD convened at the Hotel Del Coronado for it's 6th conference. In this session Health Innovation Media co-host Nick Adkins debriefs with Milind Kamkolkar, PA Consulting, Life Sciences. Segment filmed and produced for Health Innovation Media by Gregg Masters, MPH. Enjoy